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OBJECTIVES: Previous studies have demonstrated that both low and high hemoglobin concentrations are
predictive of adverse cardiovascular outcomes in various populations. However, an association of hemoglobin
with the ankle-brachial index, which is widely used as a screening test for peripheral arterial disease, has not yet
been identified.
METHODS: We examined 786 subjects (236 women and 550 men) who received routine physical check-ups.
The ankle-brachial index and several hematological parameters, including the hemoglobin level, hematocrit
and red blood cell count and other demographic and biochemical characteristics were collected. Univariate and
multivariate linear regression analyses were performed to assess the relationships between the ankle-brachial
index and the independent determinants. Receiver operating characteristic curve analysis was conducted to
calculate the cut-off level of hemoglobin for detecting a relatively low ankle-brachial index (less than 20% of all
subjects, which was 1.02).
RESULTS: The hemoglobin level, hematocrit and red blood cell count were correlated with the ankle-brachial
index in the males (r=-0.274, r=-0.224 and r=-0.273, respectively, po0.001 for all), but these associations were
not significant in the females. Multivariate linear regression analysis revealed that the independent
determinants of the ankle-brachial index included age, total cholesterol, high-density lipoprotein cholesterol
and the white blood cell count for the females and age, hypertension, total cholesterol and hemoglobin
(b=-0.001, po0.001) for the males after adjusting for confounding factors. Receiver operating characteristic
curve analysis revealed that the cut-off level of hemoglobin for detecting a low ankle-brachial index was
156.5 g/L in the males.
CONCLUSIONS: A high hemoglobin concentration was independently correlated with a low ankle-brachial
index in the healthy males, indicating that an elevation in this level may be associated with an increased
atherosclerosis risk.
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’ INTRODUCTION
Previous epidemiologic studies have shown that the
hemoglobin concentration is associated with unfavorable
cardiovascular events in the general population and in
patients with coronary arterial disease (CAD), hypertension
and heart failure (1-8). Some investigations have revealed
that a decreased hemoglobin concentration or anemia is pre-
dictive of adverse outcomes (1-4); however, accumulating
evidence demonstrates a J- or U-shaped curve for the
relationship between hemoglobin and poor prognosis in
patients with acute coronary syndrome or heart failure and
in the elderly general population (5-8). In addition, the
clinical beneficial effects of therapeutic approaches using
erythropoietin to increase the hemoglobin level are con-
troversial, an elevation in the hematocrit to above 42%
increases cardiovascular mortality (9). Therefore, a low
hemoglobin level or anemia, as well as an elevated
hemoglobin level, should be taken into consideration in
evaluation of the total risk of cardiovascular disease (CVD).
The ankle-brachial index (ABI), the ratio of lower
extremity blood pressure to upper extremity blood pressure,
is a simple and convenient method used to diagnose peri-
pheral arterial disease (PAD), which is a local manifestation
of systemic atherosclerosis. An ABI of o0.9 has been shown
to have a high sensitivity (90–97%) and specificity (98–100%)
for detecting lower extremity stenosis (10). Therefore, it has
been widely used as a screening index for PAD. PAD often
coexists with CAD and cerebrovascular disease; approxi-
mately 70% of patients with PAD have atherosclerotic
disease in other vascular beds (11). In addition, a high ABI
of X1.3 is indicative of medial arterial calcification (MAC)
(12). Thus, the normal range for the ABI may be considered
to be between 0.9 and 1.3. The ABI is associated withDOI: 10.6061/clinics/2016(07)04
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increased risks of CVD, cardiovascular mortality and
all-cause mortality (13). Hence, it has been applied exten-
sively as a screening index for cardiovascular risk estimation
in asymptomatic subjects.
Few studies have assessed the association between the
hemoglobin concentration and ABI. Moreover, the predictive
ability of hemoglobin for unfavorable outcomes has been
assessed mainly in subjects with a high CVD risk. Therefore,
the purpose of this study was to determine the relationship
between the hemoglobin level and ABI in the general
population with a normal ABI, whose CVD risk is relatively
low, to increase understanding of the potential mechanisms




We reviewed the medical records of 802 participants
who underwent routine physical examinations at the Health
Management Center of Xiangya Hospital, Central South
University, between September 2013 and December 2013.
Subjects meeting any of the following criteria were excluded:
an age of o18 or X80 years; any missing information;
an abnormal ABI (o0.9 or X1.3); severe hepatic and/or
renal dysfunction; a malignant tumor; infectious or systema-
tic inflammation; or a significant hematologic disorder.
A total of 786 participants (550 men and 236 women) were
ultimately included in this study. The study was approved
by the Xiangya Hospital ethics committee (201512536) and
informed consent was obtained from each participant.
Baseline information collection
Examinations were performed by trained medical staff of
the Health Management Center according to standard
procedures. The participants were asked about their cigarette
smoking status and past medical histories of hypertension
and diabetes mellitus. Body mass index (BMI) was calculated
as weight divided by height squared (kg/m2). Obesity was
defined as a BMIX28.0 according to the criteria of the
Working Group on Obesity in China (WGOC) (14). Systolic
and diastolic blood pressure (SBP and DBP, respectively) was
measured using a mercury sphygmomanometer in a seated
position after at least 5 minutes of rest.
Fasting blood samples were collected from an antecubital
vein after a 12-hour overnight fast. White blood cell (WBC),
hemoglobin, hematocrit, red blood cell (RBC) and platelet
counts were determined using an automated blood cell
analyzer (Beckman LH750, Bera, CA, USA). Total cholesterol,
triglyceride, high-density lipoprotein cholesterol (HDL-C),
low-density lipoprotein cholesterol (LDL-C), uric acid,
C-reactive protein (CRP) and creatinine levels were mea-
sured using an automatic biochemistry analyzer (Beckman
AU5800, Koutou-ku, Tokyo, Japan). The estimated glomer-
ular filtration rate (eGFR) was calculated using a modi-
fied Modification of Diet in Renal Disease (MDRD)
equation (15).
Hypertension was defined as an SBP and/or DBP ofX140
and/or X90 mmHg, a self-reported history of diagnosed
hypertension, or current use of an anti-hypertensive drug
(16). Diabetes mellitus was defined as a fasting serum
glucose level of X7.0 mmol/L, a self-reported history of
diagnosed diabetes, or receipt of hypoglycemic therapy (17).
Measurement of the ABI
The participants rested in the supine position for at least
5 minutes, and then SBP was measured at the ankle level
and in the brachial arteries on both sides of the body using
an automatic waveform analyzer (model BP-203RPE, Colin,
Komaki City, Japan) as previously described. Validation of
this automatic device and its reproducibility have been
previously demonstrated (18). The ABI was calculated as
ratio of ankle pressure to brachial pressure and the lower of
the bilateral ABI values for each participant was used in
analysis. Participants with an ABI of o0.9 or X1.3 were
excluded from the study.
Statistical analysis
The participants were initially classified as female or male.
The distribution of the data was assessed for normality using
the one-sample Kolmogorov-Smirnov test. Continuous vari-
ables are presented as the mean and standard deviation (SD)
and categorical variables are presented as counts and
percentages. Comparisons between groups were performed
using the two-sample t-test for continuous variables and the
chi-square test for categorical variables. Correlations
between the hematological parameters (WBC, hemoglobin,
hematocrit, RBC and platelet counts) and ABI were
examined by Pearson or Spearman correlation analysis as
appropriate. Multivariate stepwise linear regression analyses
were performed to assess the independent determinants of
the ABI. A low ABI was defined as less than 1.02 (o20th
percentile of all participants). Receiver operating character-
istics (ROC) curves were constructed to determine the
predictive values of the hemoglobin level and hematocrit
and RBC counts for a low ABI. All tests were two-tailed, and
a p-value of 5% or less was considered statistically
significant. SPSS software package (SPSS 19.0; SPSS Inc;
Chicago, IL, USA) was used for all statistical analyses.
’ RESULTS
A total of 786 eligible participants (236 women and 550
men) were included in the current study. Both the hemoglo-
bin level and ABI followed normal distributions according to
gender, as determined using the Kolmogorov-Smirnov test
(p40.05 for all). The baseline demographic and clinical
characteristics and laboratory indexes of the enrolled subjects
according to gender are summarized in Table 1. In brief,
fewer female subjects had hypertension, diabetes mellitus
or current smoking status; these subjects were unlikely to be
obese and the female subjects tended to have a lower BMI,
triglyceride, total cholesterol, uric acid and hemoglobin
levels, WBC and RBC counts and ABI and a higher HDL-
cholesterol level, eGFR and platelet count. There were no
differences in age, LDL-cholesterol or CRP between the
males and females.
We evaluated the associations of the hematological
parameters (WBC, hemoglobin, hematocrit, RBC and platelet
counts) with the ABI by Spearman or Pearson correlation
analysis, as appropriate, in the males and females separately
(Table 2). The results revealed that the WBC count (r=-0.155,
p=0.017) was negatively correlated with the ABI in the
females and that the hemoglobin level (r=-0.274, po0.001),
hematocrit (r=-0.273, po0.001) and RBC count (r=-0.224,
po0.001) were negatively correlated with the ABI in the
males. Figure 1 shows the correlations of the hemoglobin
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level and RBC and hematocrit counts with the ABI according
to gender.
Multivariate stepwise linear regression was conducted to
identify independent determinants of the ABI according to
gender. Age, hypertension, diabetes mellitus, current smok-
ing status, BMI, triglycerides, total cholesterol, HDL-choles-
terol, LDL-cholesterol, uric acid, CRP, the eGFR and the
WBC, hemoglobin, hematocrit, RBC and platelet counts were
included in the regression model. The results showed that
in the females, the independent determinants of the ABI
included age (b=0.002, po0.001), total cholesterol (b=0.011,
p=0.029), HDL-cholesterol (b=-0.035, p=0.003) and the WBC
count (b=-0.008, p=0.005). Alternatively, in the males, the
independent determinants included age (b=0.002, po0.001),
hypertension (b=0.019, p=0.002) and total cholesterol
(b=-0.007, p=0.011) and hemoglobin (b=-0.001, po0.001).
The area under the ROC curve (AUC) for hemoglobin
(AUC=0.663, 95% CI 0.605-0.721, po0.001) showed strong
discriminatory power for detecting a low ABI in the males
(Figure 2). The optimal cut-off level was 156.5 g/L (sensitiv-
ity of 57.1% and specificity of 69.1%). The predictive values
of the RBC and hematocrit counts are also indicated in
Figure 2. The ability of the hemoglobin level to predict a low
ABI in the males was slightly superior to the abilities of the
RBC (AUC=0.621, 95% CI 0.560-0.682, po0.001) and hema-
tocrit counts (AUC=0.656, 95% CI 0.597-0.716, po0.001).
’ DISCUSSION
To the best of our knowledge, this is the first study evalua-
ting the relationship between the hemoglobin concen-
tration and ABI in the general population. In this
cross-sectional study, we found strong negative associations
of hemoglobin, RBC and hematocrit with the ABI in healthy
male subjects. After adjusting for potential risk and
confounding factors, only hemoglobin remained significant
in the regression model. A relatively low ABI was defined as
1.02 (20% cut-off point of the entire population) in our study,
suggesting that subjects with a low ABI may have a higher
risk of PAD. The ROC curve indicated that the cut-off
hemoglobin level for detecting a low ABI was 156.5 g/L;
notably, a correlation between hemoglobin and the ABI was
only observed in the male subjects; this finding may be
explained by the lower range of hemoglobin in females
compared with males. Thus, the results of the present study
suggest that hemoglobin has important healthcare implica-
tions in the general population, particularly in males.
Hemoglobin, which is the main functional constituent of
RBCs, carries oxygen from the lungs to tissues of the body
and carries carbon dioxide from the tissues to the lungs.
A decreased hemoglobin concentration or anemia usually
indicates a relatively poor health status and may be a
consequence of or accompanied by certain types of chronic
comorbidities. Thus, the clinical importance of a decrease in
the hemoglobin concentration has been recognized by
physicians and some investigations have demonstrated
that this decrease is predictive of adverse outcomes in
patients with CVD and in the general population. However,
some other studies have demonstrated a J- or U-shaped
curve for the relationship between hemoglobin and poor
prognosis. In patients with acute coronary syndrome, both
low and high baseline hemoglobin levels increase the risks
of cardiovascular mortality, myocardial infarction and
recurrent ischemia (5). Patients with chronic heart failure
Table 1 - Baseline characteristics of all subjects according to
gender.
Variables Female (n=236) Male (n=550) p value
Age (years) 46.0±10.2 46.6±8.9 0.398
Hypertension (%) 38 (16.1) 140 (25.5) 0.004
Diabetes mellitus (%) 6 (2.5) 54 (9.8) o0.001
Current smoker (%) 13 (6.0) 348 (68.2) o0.001
Obesity (%) 15 (6.4) 102 (18.5) o0.001
BMI (kg/m2) 22.9±3.0 25.5±3.0 o0.001
Triglycerides (mmol/L) 1.40±1.16 2.41±2.31 o0.001
Total cholesterol (mmol/L) 4.85±0.95 5.12±1.01 o0.001
HDL-cholesterol (mmol/L) 1.68±0.37 1.41±0.36 o0.001
LDL-cholesterol (mmol/L) 2.56±0.75 2.67±0.84 0.069
Uric acid (mmol/L) 268.7±64.9 375.8±73.4 o0.001
CRP (mg/L) 2.38±1.99 2.86±4.16 0.096
eGFR (ml/min/1.73 m2) 91.4±14.8 82.84±13.0 o0.001
WBCs (x109/L) 5.88±1.47 6.44±1.65 o0.001
Hemoglobin (g/L) 129.9±10.0 152.8±10.3 o0.001
Hematocrit (%) 38.6±3.0 44.9±3.5 o0.001
RBCs (x1012/L) 4.33±0.39 4.98±0.42 o0.001
Platelet count (x109/L) 223.5±62.5 209.8±53.7 0.002
ABI 1.07±0.06 1.08±0.06 o0.001
The data are expressed as the mean ± SD or count (percentage).
BMI: body mass index; HDL: high-density lipoprotein; LDL: low-density
lipoprotein; CRP: C-reactive protein; eGFR: estimated glomerular filtration
rate; WBCs: white blood cells; RBCs: red blood cells; ABI: ankle-brachial
index.
The two-sample t-test was used for continuous variables and the
chi-square test was used for categorical variables.
Table 2 - Correlations between hematological parameters and
ankle-brachial index according to gender.
Female Male
Variable r p value r p value
WBCs -0.155 0.017 -0.058* 0.176
Hemoglobin -0.012 0.851 -0.274 o0.001
Hematocrit -0.051 0.438 -0.273 o0.001
RBCs -0.058 0.374 -0.224 o0.001
Platelet count -0.076 0.244 -0.065 0.128
WBCs: white blood cells; RBCs: red blood cells.
* : Pearson correlation analysis was performed for all variables except for
WBCs in males, as the data of WBCs did not follow a normal distribution,
necessitating the use of Spearman correlation analysis.
Table 3 - Multivariate stepwise regression analysis of
ankle-brachial index according to gender.
Covariate b 95% CI partial R2 p value
Female
Age 0.002 0.001, 0.003 0.037 o0.001
Total cholesterol 0.011 0.001, 0.020 0.024 0.029
HDL-cholesterol -0.035 -0.059, -0.012 0.038 0.003
WBCs -0.008 -0.014, -0.003 0.022 0.005
Male
Age 0.002 0.001, 0.002 0.033 o0.001
Hypertension 0.019 0.007, 0.032 0.018 0.002
Total cholesterol -0.007 -0.012, -0.002 0.001 0.011
Hemoglobin -0.001 -0.002, -0.001 0.008 o0.001
b: nonstandard regression coefficient; CI: confidence interval; WBCs:
white blood cells; HDL: high-density lipoprotein.
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who are severely anemic or polycythemic have the worst
survival rates (6). Another study of patients with chronic
heart failure has reported similar results, showing that a
very high (X17 g/dL) or reduced (o13 g/dL) hemoglobin
level is independently predictive of substantially increased
risks of death and hospitalization, regardless of the level of
systolic function (7). In addition, in an older community-
dwelling population with a normal CVD risk, low and high
Figure 1 - Correlations of the ankle-brachial index with hemoglobin, RBC and hematocrit according to gender (the top row is for
females, and the bottom row is for males). ABI: ankle-brachial index; RBC: red blood cell.
Figure 2 - Receiver operating characteristic curves for various blood parameters in detecting a low ankle-brachial index (less than 20%
of all subjects, which was 1.02).
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hemoglobin concentrations have been demonstrated to be
independently associated with increased mortality (8).
Thus, the adjusted risk of poor outcome associated with a
high hemoglobin level is similar to and not lower than that
associated with a low hemoglobin level.
The hemoglobin concentration in blood varies minimally
with hematocrit, which is the proportion of the blood that
consists of packed RBCs. A previous study has indicated that
hematocrit is strongly correlated with the hemoglobin level
(6); thus, the hematocrit is usually used as a surrogate
marker for hemoglobin. A high hematocrit has been shown
to be predictive of subsequent mortality in patients with
ischemic stroke (19). A health survey study has demon-
strated that a slightly elevated hematocrit is associated with
an increase in coronary heart disease mortality after 28 years
of follow-up (20). In addition, a study involving hematocrit
measurement has demonstrated a U-shaped pattern for
cardiovascular or non-cardiovascular mortality in hyperten-
sive adults (21). In the current study, we recorded both the
baseline hemoglobin concentration and hematocrit, and
univariate regression analysis revealed that both of these
parameters were correlated with the ABI and had semblable
discriminating abilities for detecting a low ABI. However,
multivariate stepwise regression analysis, in which hemoglo-
bin, hematocrit and other potential covariates were simulta-
neously considered, revealed that after adjustments, only
hemoglobin, and not hematocrit, remained as an independent
determinant of the ABI. There is a lack of studies examining
which parameter is superior to the others for detecting a low
ABI and thus the risk of CVD therefore, further study is
required.
The independent association of hemoglobin with the ABI
detected in the present study was restricted to the male
subjects. The main reason for this discrepancy is the differing
distributions of hemoglobin levels between the males and
females, as the females had a lower range of hemoglobin
than the males, in agreement with previous studies (3,5-7).
Further, ROC curve analysis revealed that the cut-off level for
detecting a low ABI in the males was 156.5 g/L; only 0.8% of
the females' hemoglobin levels were above this cut-off level
(compared with 35.3% of the males). Notably, other
covariates affect the relationship of hemoglobin with the
ABI, but they were not adjusted for in our study. Although
some studies have shown that the relationship between
hemoglobin and adverse outcomes is independent after
adjusting for covariates, including gender (5-7), it is better to
divide participants according to gender when determining
optimal hemoglobin ranges (3).
The mechanism underlying the association between
hemoglobin and arterial stiffness or atherosclerosis has not
yet been elucidated. The main mechanism may involve an
increase in blood viscosity due to a high hemoglobin
concentration. Notably, blood viscosity is closely associated
with carotid and coronary atherosclerosis (22,23), cerebral
atherogenesis (24), common carotid artery elasticity (25) and
increased vascular resistance, resulting in decreased coron-
ary blood flow (26) and reduced cerebral reperfusion after
acute stroke Another mechanism may involve an increase in
blood pressure due to an elevated hemoglobin concentration
(1,8), resulting in an increased risk of thrombosis (28).
Moreover, hemoglobin participate in atherogenesis. Erythro-
cytes are prone to lyse in advanced atheromatous lesions,
releasing hemoglobin. Hemoglobin is oxidized to ferri- and
ferrylhemoglobin and released heme and iron promote
further oxidation of lipids, amplifying the endothelial cell
cytotoxicity of plaque components (29).
The major limitations of this study are its cross-sectional
and observational nature and limited sample size; in
particular, the sample size of the female participants was
relatively smaller than that of the males. However, potential
confounding factors were adjusted for in our study, suggest-
ing that the relationship observed between hemoglobin and
the ABI in males is a valid finding. In addition, our study
recruited general subjects undergoing routine physical
examinations, so our findings should be interpreted with
caution. Moreover, we excluded those participants with an
ABI of o0.9 or X1.3 before analysis, as the proportion of
participants with an ABI of o0.9 was extremely low (0.8%).
Therefore, our study failed to determine the predictive ability
of hemoglobin for PAD and future study is warranted.
Finally, the findings regarding the impact of the hemoglobin
concentration on dynamic changes in the ABI over time may
be more convincing and further study is necessary.
In conclusion, in healthy males, the hemoglobin concen-
tration was negatively and independently associated with
the ABI. Accordingly, subjects with an elevated hemoglobin
concentration may be at an increased risk of PAD. Further
investigation is necessary to confirm these findings.
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